BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 27514955)

  • 1. Prevalence of high-risk human papilloma virus types and cervical smear abnormalities in female sex workers in Chandigarh, India.
    Singh MP; Kaur M; Gupta N; Kumar A; Goyal K; Sharma A; Majumdar M; Gupta M; Ratho RK
    Indian J Med Microbiol; 2016; 34(3):328-34. PubMed ID: 27514955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of high-risk human papillomavirus and abnormal pap smears in female sex workers compared to the general population in Antwerp, Belgium.
    Vorsters A; Cornelissen T; Leuridan E; Bogers J; Vanden Broeck D; Benoy I; Goossens H; Hens N; Van Damme P
    BMC Public Health; 2016 Jun; 16():477. PubMed ID: 27266509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic human papilloma virus and cervical pre-cancerous lesions in brothel-based sex workers in India.
    Sarkar K; Bhattacharya S; Bhattacharyya S; Chatterjee S; Mallick AH; Chakraborti S; Chatterjee D; Bal B
    J Infect Public Health; 2008; 1(2):121-8. PubMed ID: 20701853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr Virus, High-Risk Human Papillomavirus and Abnormal Cervical Cytology in a Prospective Cohort of African Female Sex Workers.
    Cameron JE; Rositch AF; Vielot NA; Mugo NR; Kwatampora JKL; Waweru W; Gilliland AE; Hagensee ME; Smith JS
    Sex Transm Dis; 2018 Oct; 45(10):666-672. PubMed ID: 29664764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of abnormal cervical smears in a hospital cohort of French women beyond the upper age limit screening program.
    Luquain A; Belglaiaa E; Guenat D; Vrecko S; Riethmuller D; Valmary-Degano S; Bedgedjian I; Chouham S; Prétet JL; Mougin C
    Prev Med; 2015 Dec; 81():157-62. PubMed ID: 26348451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey.
    Ferré VM; Ekouevi DK; Gbeasor-Komlanvi FA; Collin G; Le Hingrat Q; Tchounga B; Salou M; Descamps D; Charpentier C; Dagnra AC
    Clin Microbiol Infect; 2019 Dec; 25(12):1560.e1-1560.e7. PubMed ID: 31051265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
    Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests.
    Zhao C; Elishaev E; Yuan KH; Yu J; Austin RM
    Cancer; 2007 Oct; 111(5):292-7. PubMed ID: 17879368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk human papilloma virus prevalence and its relation with abnormal cervical cytology among Turkish women.
    Özcan ES; Taşkin S; Ortaç F
    J Obstet Gynaecol; 2011 Oct; 31(7):656-8. PubMed ID: 21973143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Chlamydia trachomatis in High-Risk Human Papillomavirus Persistence Among Female Sex Workers in Nairobi, Kenya.
    Vielot N; Hudgens MG; Mugo N; Chitwa M; Kimani J; Smith J
    Sex Transm Dis; 2015 Jun; 42(6):305-11. PubMed ID: 25970306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevaccination distribution of human papillomavirus types in Italian women with high-risk lesions and cervical neoplasia.
    De Francesco MA; Gargiulo F; Schreiber C; Ciravolo G; Salinaro F; Manca N
    Intervirology; 2010; 53(6):417-25. PubMed ID: 20606464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
    Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal high-risk human papillomavirus infection in a cross-sectional study among women of six different ethnicities in Amsterdam, the Netherlands: the HELIUS study.
    Alberts CJ; Vos RA; Borgdorff H; Vermeulen W; van Bergen J; Bruisten SM; Geerlings SE; Snijder MB; van Houdt R; Morré SA; de Vries HJ; van de Wijgert JH; Prins M; Schim van der Loeff MF
    Sex Transm Infect; 2016 Dec; 92(8):611-618. PubMed ID: 27188273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk human papillomaviruses distribution in Romanian women with negative cytology.
    Plesa A; Socolov D; Huica I; Botezatu A; Iancu IV; Ungureanu C; Teleman S; Albulescu A; Fudulu A; Anton G
    J Infect Dev Ctries; 2019 Apr; 13(4):326-333. PubMed ID: 32045377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and distribution of oncogenic strains of human papilloma virus in women presenting for cervical cancer screening in Port Harcourt, Nigeria.
    Kennedy NT; Ikechukwu D; Goddy B
    Pan Afr Med J; 2016; 23():85. PubMed ID: 27222684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estimation of HPV infection presence in cytological smears in a group of asymptomatic women].
    Łukaszuk K; Liss J; Zalewski J; Roter M; Brzóska B; Debniak J
    Wiad Lek; 2001; 54(9-10):508-15. PubMed ID: 11816294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush.
    Brink AA; Meijer CJ; Wiegerinck MA; Nieboer TE; Kruitwagen RF; van Kemenade F; Fransen Daalmeijer N; Hesselink AT; Berkhof J; Snijders PJ
    J Clin Microbiol; 2006 Jul; 44(7):2518-23. PubMed ID: 16825374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.